Blog

Ajanta Pharma Buyback – What’s in it for Investors?
Comments0

 

The Board of Directors of Ajanta Pharma Limited at its meeting held on November 3, 2020 has approved a proposal of buyback along with the Q2FY21 Results.

Buyback Details

 Buy Back Size (In Cr.)

135.97

 Number of Shares

735000

 Buyback Offer Size

0.84% of Total number of shares

 FV (In Rs.)

2

 Buyback Price (In Rs.)

1850

 Closing on announcement day

1609

 Premium

14.9%

 Record Date

November 13, 2020

About Ajanta Pharma

Ajanta Pharma Limited (APL) is a multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations. It has a presence in India, the United States, and about 30 other countries in Africa, Asia, Middle East, and CIS. It was established in 1973.

They serve wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products.

Q2 FY21 Performance Highlights

  1. On a consolidated basis, the company's net profit increased 46.29% to Rs 170.22 crore on a 11.38% rise in revenue from operations to Rs 715.91 crore in Q2 September 2020 over Q2 September 2019.
  2. Profit before tax (PBT) jumped 54.27% to Rs 249.24 crore in Q2 September 2020 over Q2 September 2019.
  3. EBITDA rose 54% to Rs 274 crore in Q2 September 2020 over Q2 September 2019. EBITDA is at 38% of revenue from operations.
  4. Total exports in Q2 September 2020 were at Rs 499 crore, a growth of 12% year-on-year. During Q2 September 2020, R&D expenses declined 27.5% to Rs 29 crore (4% of revenue) from Rs 40 crore in Q2 September 2019.
  5. The board has also approved payment of interim dividend of Rs 9.50 per equity share along with results and Buyback, record date is on 13 November 2020.

Financials

 (In Cr.)

Sep-20

Jun-20

Mar-20

Dec-19

 Revenue

676.51

560.85

560.68

530.55

 Total Income

762.75

573.95

614.78

581.72

 Interest

-1.35

-1.2

-2.93

-0.84

 Tax

-83.31

-42.78

-41.11

-57.45

 Net Profit

225.22

115.69

88.51

108.32

 Equity

17.54

17.54

17.54

17.54

 EPS

25.81

13.26

10.14

12.41

 NPM %

33.29

20.63

15.79

20.42


Pre-Buyback shareholding pattern as on October 30, 2020

 

Minimum Acceptance Ratio

 Shares Reserved for Retail

1,10,250 (15% of 735000)

 Total Retail Shares

63,58,011

 Minimum Acceptance Ratio Retail

1.73%

 Non - Retail  Sahres

6,24,750 (85%)

 Minimum acceptance Ratio Non-Retail (Approx.)

0.77%

  1. To be eligible for the buyback the investor should have shares of Ajanta Pharma in demat or physical form as on record date.
  2. Investment should be less than equal to Rs. 2 Lacs to qualify as retail Investor.
  3. Final Acceptance ratio for retail and non-retail category is calculated as the ratio of Number of shares offered in each category divided by Total number of shares tendered in each category.
  4. Prior to this buyback Ajanta Pharma has done buyback in February 2019 at a price of 1300.

Profit from Buyback based on acceptance ratio

For Retail Investors =2,00,000/1850=108

Buy 108 Shares at Rs.1573 (Closing of 9th Nov’20)

 Acceptance Ratio

33%

50%

75%

100%

 Amount Invested in Buyback

169884

169884

169884

169884

 No. of Shares buyback

36

54

81

108

 BuyBack Profit

9872

14958

22437

29916

 Profit

5.81%

8.80%

13.21%

17.61%

 

 

Disclaimer

Author Image

Comment

Most Commented Posts

  • PC Jeweller Demerges its Expo..

    What’s the deal? PC Jewelers recently announced that it would demerge its Export Division and merge with its wholly owned subsidiary - PCJ Gems & Jewellery Limited. Company c..

  • Insurance- Introduction

    Risk and uncertainty are associated with life in some of the other ways. These risks and uncertainties are increasing daily because of the increment in the speed of life. For example, i..

  • Rail Vikas Nigam Ltd. IPO

      Offer Details Price band Rs 17-19 Per Equity Share Offer Open Date Mar 29, 2019 Offer Close Date Apr 03, 2019 Lot Size..

  • Tech Mahindra Buyback

    The Board of Directors of Tech Mahindra Ltd. approved a share buyback for its investors on Feb 21, 2019. The details of the buyback include: Ex-Date: March 5th, 2019 Record Date: Marc..

  • BHEL Buyback

    The Board of Directors of BHEL approved a share buyback for its investors on Oct 25, 2018. The details of the buyback include:  Record Date: November 6th, 2018 Buyback price: Rs...